GloGlo (YC) researcher Piotr Witkowski and Gary Meininger shared two different approaches to replacing the insulin-producing cells destroyed by type 1 diabetes.

Public source

Publisher name

Public post

screening a child for early signs of type 1 diabetes can reduce their chance of being dangerously sick at diagnosis from around 50% to around 3%. but almost nobody gets…

Log in to read the full post

Company

About GloGlo (YC)

GloGlo is building a new consumer health brand for diabetics and the glucose-conscious. Our first products are the GloGlo AI glucose companion, which turns continuous glucose data into personalized insights and practical guidance, and GloGlo Energy Gummies, a fast, convenient, and enjoyable source of glucose for exercise, daily energy, and managing lows. We are starting with the Type 1 diabetes community, where glucose management is urgent and constant, before expanding to athletes and the broader metabolic health market. Our long-term vision is to make managing glucose and energy simpler, more intuitive, and more human. Backed by Y Combinator.

See more

Latest activity

8 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.